These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].
    Author: Grzegorzewska A, Krzymański M, Antoniewicz K.
    Journal: Pol Tyg Lek; ; 49(6-7):137-40. PubMed ID: 8090666.
    Abstract:
    This study aimed at evaluating an effect of repeated intraperitoneal furosemide administration on plasma proteins in patients with uremia given the drug to increase intermittent peritoneal dialysis efficiency. Patients (n = 6) dialysed for 48-60 hours per week furosemide was added to dialysis fluid in the dose of 1.2-2.0 g per 1 dialysis weekly for 3 months. A control group consisted of patients (n = 6) dialysed without furosemide. Plasma total proteins, albumin, total globulins, IgG, and IgA were determined in all patients. At the same time, plasma furosemide levels were monitored. A 3-month treatment with dialyses supplemented with furosemide decreased plasma protein levels especially IgG (p < 0.5) in comparison with dialyses without the drug. Furosemide plasma levels remained below ototoxic levels (over 50 micrograms/mL) during the treatment.
    [Abstract] [Full Text] [Related] [New Search]